The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment

SK Kim, SW Cho - Frontiers in pharmacology, 2022 - frontiersin.org
Recently, in the field of cancer treatment, the paradigm has changed to immunotherapy that
activates the immune system to induce cancer attacks. Among them, immune checkpoint …

The metabolism of cancer cells during metastasis

G Bergers, SM Fendt - Nature Reviews Cancer, 2021 - nature.com
Metastasis formation is the major cause of death in most patients with cancer. Despite
extensive research, targeting metastatic seeding and colonization is still an unresolved …

Metabolic support of tumour-infiltrating regulatory T cells by lactic acid

MLJ Watson, PDA Vignali, SJ Mullett… - Nature, 2021 - nature.com
Regulatory T (Treg) cells, although vital for immune homeostasis, also represent a major
barrier to anti-cancer immunity, as the tumour microenvironment (TME) promotes the …

Lactate in the tumour microenvironment: From immune modulation to therapy

ZH Wang, WB Peng, P Zhang, XP Yang, Q Zhou - EBioMedicine, 2021 - thelancet.com
Disordered metabolic states, which are characterised by hypoxia and elevated levels of
metabolites, particularly lactate, contribute to the immunosuppression in the tumour …

Engineered biomimetic nanoparticles achieve targeted delivery and efficient metabolism-based synergistic therapy against glioblastoma

G Lu, X Wang, F Li, S Wang, J Zhao, J Wang… - Nature …, 2022 - nature.com
Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few
treatment options. Here, building on the observation of elevated lactate (LA) in resected …

Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer

F Cappellesso, MP Orban, N Shirgaonkar, E Berardi… - Nature Cancer, 2022 - nature.com
Solid tumors are generally characterized by an acidic tumor microenvironment (TME) that
favors cancer progression, therapy resistance and immune evasion. By single-cell RNA …

Lactate: a metabolic driver in the tumour landscape

L Ippolito, A Morandi, E Giannoni, P Chiarugi - Trends in biochemical …, 2019 - cell.com
The presence of lactate in human tumours has been long neglected, confined to the role of a
waste product derived from glycolysis and as a biomarker of malignancy. More recently …

Engineering lactate-modulating nanomedicines for cancer therapy

J Chen, Y Zhu, C Wu, J Shi - Chemical Society Reviews, 2023 - pubs.rsc.org
Lactate in tumors has long been considered “metabolic junk” derived from the glycolysis of
cancer cells and utilized only as a biomarker of malignancy, but is presently believed to be a …

Biodegradable ferrous sulfide-based nanocomposites for tumor theranostics through specific intratumoral acidosis-induced metabolic symbiosis disruption

J Wang, Z Sun, S Wang, C Zhao, J Xu… - Journal of the …, 2022 - ACS Publications
Abnormal metabolic symbiosis is a typical characteristic that differentiates the tumor regions
from healthy tissues and meanwhile maintains tumor survival. It is of great potential to …

TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells

C Corbet, E Bastien, JP Santiago de Jesus… - Nature …, 2020 - nature.com
Acidosis, a common characteristic of the tumor microenvironment, is associated with
alterations in metabolic preferences of cancer cells and progression of the disease. Here we …